https://healthandpharma.net/illumina-d3b-genome-pediatric-cancer-rare-disease Health and Pharma en 2026-04-15T00:00:00+00:00 Illumina and D3b Launch 100 K Genome Effort to Advance Pediatric Cancer and Rare Disease Research https://healthandpharma.net/bizengri-zenocutuzumab-fda-bla-cholangiocarcinoma Health and Pharma en 2026-04-15T00:00:00+00:00 Zenocutuzumab Gains NCCN Support as FDA Review Advances in Cholangiocarcinoma